Table 2. Phenotype characteristics of BM-MSCs (n = 11).
Surface markers | Control (%) | AA (%) |
CD34 | - | - |
CD45 | - | - |
CD73 | 99.71±0.16 | 99.55±0.03 |
CD105 | 87.45±5.19 | 75.88±22.28 |
CD90 | 83.77±1.85 | 89.55±1.95 |
CD44 | 99.63±0.06 | 99.61±0.11 |
CD29 | 99.52±0.17 | 99.64±0.07 |
CD49e | 98.18±0.66 | 98.68±0.7 |
CD166 | 94.09±3.99 | 85.72±8.11 |
HLA-ABC | 99.71±0.16 | 99.71±0.16 |
HLA-DR | - | - |